264 related articles for article (PubMed ID: 37460669)
1. Iron oxide nanoparticles as positive T
Oberdick SD; Jordanova KV; Lundstrom JT; Parigi G; Poorman ME; Zabow G; Keenan KE
Sci Rep; 2023 Jul; 13(1):11520. PubMed ID: 37460669
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. Large T
Yin X; Russek SE; Zabow G; Sun F; Mohapatra J; Keenan KE; Boss MA; Zeng H; Liu JP; Viert A; Liou SH; Moreland J
Sci Rep; 2018 Aug; 8(1):11863. PubMed ID: 30089881
[TBL] [Abstract][Full Text] [Related]
4. Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.
Clavijo Jordan MV; Beeman SC; Baldelomar EJ; Bennett KM
Contrast Media Mol Imaging; 2014; 9(5):323-32. PubMed ID: 24764110
[TBL] [Abstract][Full Text] [Related]
5. The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study.
Khalkhali M; Rostamizadeh K; Sadighian S; Khoeini F; Naghibi M; Hamidi M
Daru; 2015 Sep; 23(1):45. PubMed ID: 26381740
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL
J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695
[TBL] [Abstract][Full Text] [Related]
7. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
8. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
9. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
10. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
11. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
[TBL] [Abstract][Full Text] [Related]
12. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
13. Scaling Laws at the Nano Size: The Effect of Particle Size and Shape on the Magnetism and Relaxivity of Iron Oxide Nanoparticle Contrast Agents.
Smolensky ED; Park HY; Zhou Y; Rolla GA; Marjańska M; Botta M; Pierre VC
J Mater Chem B; 2013 Jun; 1(22):2818-2828. PubMed ID: 23819021
[TBL] [Abstract][Full Text] [Related]
14. Influence of SPION Surface Coating on Magnetic Properties and Theranostic Profile.
Ferreira-Filho VC; Morais B; Vieira BJC; Waerenborgh JC; Carmezim MJ; Tóth CN; Même S; Lacerda S; Jaque D; Sousa CT; Campello MPC; Pereira LCJ
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675647
[TBL] [Abstract][Full Text] [Related]
15. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Specific Targeting of Triptorelin-Conjugated Dextran-Coated Magnetite Nanoparticles as a Targeted Probe in GnRH
Yousefvand M; Mohammadi Z; Ghorbani F; Irajirad R; Abedi H; Seyedi S; Papi A; Montazerabadi A
Contrast Media Mol Imaging; 2021; 2021():5534848. PubMed ID: 34104122
[TBL] [Abstract][Full Text] [Related]
18. Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity.
Hong GB; Zhou JX; Yuan RX
Int J Nanomedicine; 2012; 7():2863-72. PubMed ID: 22745549
[TBL] [Abstract][Full Text] [Related]
19. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
20. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
